Fulcrum Therapeutics Inc —— 资产负债表 (NASDAQ:FULC) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 129.58 M235 M226.69 M257.69 M260.72 M366.28 M 负债总额 34.4 M23.46 M27.74 M22.5 M17.68 M17.28 M 权益总额 95.18 M211.54 M198.94 M235.19 M243.03 M349 M 负债及股东权益总额 129.58 M235 M226.69 M257.69 M260.72 M366.28 M 总债务 —————— 净债务 ——————

新闻

Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher

Fulcrum Therapeutics在Leerink会议上聚焦镰状细胞病战略

Fulcrum Therapeutics at Leerink Conference: Strategic Focus on Sickle Cell

Stifel称Ipsen撤药可能给Fulcrum Therapeutics股价带来压力

Fulcrum Therapeutics stock may face pressure on Ipsen withdrawal, Stifel says

Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)

Fulcrum Therapeutics股价下跌,镰状细胞病试验未达目标

Fulcrum Therapeutics stock falls as sickle cell trial misses target

Leerink重申Fulcrum Therapeutics股票评级,基于镰状细胞病数据

Leerink reiterates Fulcrum Therapeutics stock rating on SCD data

美国银行重申Fulcrum Therapeutics股票评级为跑输大盘,目标价7美元

BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7